TAp63γ and ΔNp63β Promote Osteoblastic Differentiation of Human Mesenchymal Stem Cells: Regulation by Vitamin D3 Metabolites

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2015 Apr 8

PMID 25849854

Citations 5

Authors

Kevin M Curtis

Kristina K Aenlle

Rachel N Frisch

Guy A Howard

Affiliations

Soon will be listed here.

Abstract

The transcription factor p63 is required for skeletal formation, and is important for the regulation of 1α,25(OH)2D3 receptor (VDR) in human mesenchymal stem cells (hMSC). Herein we report that TAp63γ and ΔNp63β appear to be an integral part of the osteoblastic differentiation of hMSC and are differentially regulated by the vitamin D3 metabolites 1α,25(OH)2D3 and 24R,25(OH)2D3. We compared the endogenous expression of p63 isoforms (TA- and ΔNp63) and splice variants (p63α, -β, -γ), in naive hMSC and during osteoblastic differentiation of hMSC. TAp63α and -β were the predominant p63 variants in naive, proliferating hMSC. In contrast, under osteoblastic differentiation conditions, expression of p63 changed from the TAp63α and -β to the TAp63γ and ΔNp63β variants. Transient overexpression of the p63 variants demonstrated that TAp63β, ΔNp63β, and ΔNp63γ increased alkaline phosphatase activity and ΔNp63α and -γ increased the expression of mRNA for osteocalcin and osterix. Our results support the hypothesis that TAp63α and -β promote a naive state in hMSC. Moreover, TAp63γ is increased during and promotes early osteoblastic differentiation through the expression of pro-osteogenic genes; VDR, Osterix, Runx2 and Osteopontin. ΔNp63β also appears to support osteogenic maturation through increased alkaline phosphatase activity. Treatment with 1α,25(OH)2D3 increased the expression of mRNA for ΔNp63, while addition of 24R,25(OH)2D3 increased the expression of TA- and ΔNp63γ variants. These novel findings demonstrate for the first time that p63 variants are differentially expressed in naive hMSC (TAp63α,β), are important during the osteoblastic differentiation of hMSC (TAp63γ and ΔNp63β), and are differentially regulated by the vitamin D3 metabolites, 1α,25(OH)2D3 and 24R,25(OH)2D3. The molecular nuances and mechanisms of osteoblastic differentiation presented here will hopefully improve our understanding of bone development, complications in bone repair (mal- and non-union fractures), osteoporosis and possibly lead to new modalities of treatment.

Citing Articles

The Splicing Factor PTBP1 Represses Isoform Production in Squamous Cell Carcinoma.

Taylor W, Deschamps S, Reboutier D, Paillard L, Mereau A, Audic Y Cancer Res Commun. 2023; 2(12):1669-1683.

PMID: 36970727 PMC: 10035508. DOI: 10.1158/2767-9764.CRC-22-0350.

Development and validation of a gene signature predicting the risk of postmenopausal osteoporosis.

Yuan W, Yang M, Zhu Y Bone Joint Res. 2022; 11(8):548-560.

PMID: 35920104 PMC: 9396926. DOI: 10.1302/2046-3758.118.BJR-2021-0565.R1.

Pin1 and JNK1 cooperatively modulate TAp63γ.

Fan X, He W, Hu K, Chen H, Chen L, Fan S FEBS Open Bio. 2021; 11(3):890-897.

PMID: 33548094 PMC: 7931219. DOI: 10.1002/2211-5463.13109.

ErbB2-driven downregulation of the transcription factor Irf6 in breast epithelial cells is required for their 3D growth.

Khan I, Yoo B, McPhee M, Masson O, Surette A, Dakin-Hache K Breast Cancer Res. 2018; 20(1):151.

PMID: 30545388 PMC: 6293553. DOI: 10.1186/s13058-018-1080-1.

Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1 regulatory B cell expansion.

Ye L, Zhang Q, Cheng Y, Chen X, Wang G, Shi M J Immunother Cancer. 2018; 6(1):145.

PMID: 30526680 PMC: 6288912. DOI: 10.1186/s40425-018-0451-6.

References

Petitjean A, Ruptier C, Tribollet V, Hautefeuille A, Chardon F, Cavard C . Properties of the six isoforms of p63: p53-like regulation in response to genotoxic stress and cross talk with DeltaNp73. Carcinogenesis. 2007; 29(2):273-81. DOI: 10.1093/carcin/bgm258. View

Boyer L, Lee T, Cole M, Johnstone S, Levine S, Zucker J . Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005; 122(6):947-56. PMC: 3006442. DOI: 10.1016/j.cell.2005.08.020. View

Studer D, Lischer S, Jochum W, Ehrbar M, Zenobi-Wong M, Maniura-Weber K . Ribosomal protein l13a as a reference gene for human bone marrow-derived mesenchymal stromal cells during expansion, adipo-, chondro-, and osteogenesis. Tissue Eng Part C Methods. 2012; 18(10):761-71. PMC: 3460615. DOI: 10.1089/ten.TEC.2012.0081. View

Lu Y, Abbassi S, Li F, Ding M, Wu G, Gu J . Distinct function of P63 isoforms during embryonic skeletal development. Gene. 2013; 519(2):251-9. PMC: 3628837. DOI: 10.1016/j.gene.2013.02.021. View

Cheng W, Jacobs W, Zhang J, Moro A, Park J, Kushida M . DeltaNp63 plays an anti-apoptotic role in ventral bladder development. Development. 2006; 133(23):4783-92. DOI: 10.1242/dev.02621. View

Chen K, Aenlle K, Curtis K, Roos B, Howard G . Hepatocyte growth factor (HGF) and 1,25-dihydroxyvitamin D together stimulate human bone marrow-derived stem cells toward the osteogenic phenotype by HGF-induced up-regulation of VDR. Bone. 2012; 51(1):69-77. DOI: 10.1016/j.bone.2012.04.002. View

DIppolito G, Howard G, Roos B, Schiller P . Sustained stromal stem cell self-renewal and osteoblastic differentiation during aging. Rejuvenation Res. 2006; 9(1):10-9. DOI: 10.1089/rej.2006.9.10. View

Mills A, Zheng B, Wang X, Vogel H, Roop D, Bradley A . p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature. 1999; 398(6729):708-13. DOI: 10.1038/19531. View

Kommagani R, Caserta T, Kadakia M . Identification of vitamin D receptor as a target of p63. Oncogene. 2006; 25(26):3745-51. DOI: 10.1038/sj.onc.1209412. View

10.

Atlasi Y, Mowla S, Ziaee S, Gokhale P, Andrews P . OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells. Stem Cells. 2008; 26(12):3068-74. DOI: 10.1634/stemcells.2008-0530. View

11.

Linsley C, Wu B, Tawil B . The effect of fibrinogen, collagen type I, and fibronectin on mesenchymal stem cell growth and differentiation into osteoblasts. Tissue Eng Part A. 2013; 19(11-12):1416-23. DOI: 10.1089/ten.TEA.2012.0523. View

12.

Curtis K, Aenlle K, Roos B, Howard G . 24R,25-dihydroxyvitamin D3 promotes the osteoblastic differentiation of human mesenchymal stem cells. Mol Endocrinol. 2014; 28(5):644-58. PMC: 4004781. DOI: 10.1210/me.2013-1241. View

13.

Curtis K, Gomez L, Rios C, Garbayo E, Raval A, Perez-Pinzon M . EF1alpha and RPL13a represent normalization genes suitable for RT-qPCR analysis of bone marrow derived mesenchymal stem cells. BMC Mol Biol. 2010; 11:61. PMC: 2931506. DOI: 10.1186/1471-2199-11-61. View

14.

Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson R . p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature. 1999; 398(6729):714-8. DOI: 10.1038/19539. View

15.

Wolff S, Talos F, Palacios G, Beyer U, Dobbelstein M, Moll U . The alpha/beta carboxy-terminal domains of p63 are required for skin and limb development. New insights from the Brdm2 mouse which is not a complete p63 knockout but expresses p63 gamma-like proteins. Cell Death Differ. 2009; 16(8):1108-17. PMC: 2778344. DOI: 10.1038/cdd.2009.25. View

16.

Gu J, Lu Y, Qiao L, Ran D, Li N, Cao H . Mouse p63 variants and chondrogenesis. Int J Clin Exp Pathol. 2013; 6(12):2872-9. PMC: 3843267. View

17.

van Bokhoven H, Brunner H . Splitting p63. Am J Hum Genet. 2002; 71(1):1-13. PMC: 384966. DOI: 10.1086/341450. View

18.

Schneider C, Rasband W, Eliceiri K . NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012; 9(7):671-5. PMC: 5554542. DOI: 10.1038/nmeth.2089. View

19.

Yang A, Kaghad M, Wang Y, Gillett E, Fleming M, Dotsch V . p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell. 1998; 2(3):305-16. DOI: 10.1016/s1097-2765(00)80275-0. View

20.

Aenlle K, Curtis K, Roos B, Howard G . Hepatocyte growth factor and p38 promote osteogenic differentiation of human mesenchymal stem cells. Mol Endocrinol. 2014; 28(5):722-30. PMC: 4004777. DOI: 10.1210/me.2013-1286. View